Align Technology, Inc.
HealthcareNASDAQ:ALGN · NASDAQ Global Select
-$1.67 today
Vol 0.48M · Avg 1.10M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
10.1%
avg 21.9%
ROIC
9.9%
avg 16.5%
ROA
6.6%
avg 13.9%
Analysis
ROE is currently the strongest return metric at 10.1% versus its period average of 21.9%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Joseph Hogan | President, Chief Executive Officer & Director | $2.64M | — | 69 | $135,916.00 | 0.19% |
Zelko Relic | Executive Vice President & Chief Technology Officer | $1.06M | — | 61 | $36,502.00 | 0.05% |
John F. Morici | Chief Financial Officer & Executive Vice President of Global Finance | $1.02M | — | 59 | $17,102.00 | 0.02% |
Emory Wright | Executive Vice President of Direct Fabrication Platform & Operations | $998,961.00 | — | 56 | $10,049.00 | 0.01% |
Julie Ann Coletti | Executive Vice President and Chief Legal & Regulatory Officer | $941,121.00 | — | 58 | $13,163.00 | 0.02% |
Richardson Jaime Holte | Executive Vice President of Global Human Resources | $790,869.00 | — | — | $937.00 | <0.01% |
Stuart Hockridge | Executive Vice President of Global Human Resources | $790,869.00 | — | 54 | $16,102.00 | 0.02% |
Sreelakshmi Kolli | Executive Vice President & Chief Product and Digital Officer | — | — | 51 | $20,972.00 | 0.03% |
Mitra Derakhshan | Executive VP, Chief Clinical Officer, Global Treatment Planning & Clinical Services | — | — | — | — | — |
Frank Quinn | Executive VP & MD of Americas Region | — | — | — | — | — |
David Carr | Executive VP and MD of EMEA | — | — | — | — | — |
JunHo Han | Executive VP & MD of Asia Pacific | — | — | — | — | — |
Shirley Stacy | Vice President of Corporation Communications & Investor Relations | — | — | — | — | — |
Srini Kaza | Executive Vice President of Research & Development | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
2
$1.00M
Sells
1
$1.51M
Net Sentiment
$507,908.88
Net selling
Most Active
Morici John
1 transactions
Analysis
Insiders reported 2 buys worth $1.00M and 1 sells worth $1.51M over the last 12 months. That adds up to net selling of $507,908.88. Morici John was the most active insider with 1 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +35.6% | +16.9% (14yr)1 analysts |
| Revenue | N/A | N/A | +14.7% | +13.4% (14yr)5 analysts |
| Net Income | N/A | N/A | +34.9% | +16.0% (14yr)5 analysts |
| EBIT | N/A | N/A | +30.1% | +11.7% (14yr)5 analysts |
Analysis
Recent growth has been strongest in EPS at +35.6% over three years. Forward estimates point to EPS at +16.9% (14yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Exelixis, Inc.
NASDAQ:EXEL
$13.35B
Penumbra, Inc.
NYSE:PEN
$12.54B
Revvity, Inc.
NYSE:RVTY
$11.12B
Globus Medical, Inc.
NYSE:GMED
$10.84B
BioMarin Pharmaceutical Inc.
NASDAQ:BMRN
$10.81B
The Ensign Group, Inc.
NASDAQ:ENSG
$8.73B
Bio-Rad Laboratories, Inc.
NYSE:BIO
$7.73B
Qiagen N.V.
NYSE:QGEN
$7.64B
Hims & Hers Health, Inc.
NYSE:HIMS
$5.98B
Who manages ALGN?
Align Technology, Inc. (ALGN) lists 14 active executives. The top listed executive is Emory Wright, Executive Vice President of Direct Fabrication Platform & Operations.
Are ALGN insiders buying or selling?
Recent insider activity shows net selling of $16.83M.
Explore More
Continue the stock analysis
Jump to another research area for this company.